CDKN2A germline mutations in UK patients with multiple primary melanomas and familial melanoma

被引:0
|
作者
MacKie, RM [1 ]
Andrew, N [1 ]
Lanyon, WG [1 ]
Connor, JM [1 ]
机构
[1] Univ Glasgow, Dept Dermatol & Med Genet, Glasgow, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
110
引用
收藏
页码:573 / 573
页数:1
相关论文
共 50 条
  • [21] Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma
    Alexandre Leon Ribeiro de Ávila
    Ana Cristina Victorino Krepischi
    Luciana Facure Moredo
    Talita Ferreira Marques Aguiar
    Felipe Carneiro da Silva
    Bianca Costa Soares de Sá
    Amanda França de Nóbrega
    Maria Isabel Waddington Achatz
    João Pedreira Duprat
    Gilles Landman
    Dirce Maria Carraro
    Familial Cancer, 2014, 13 : 645 - 649
  • [22] The role of the CDKN2A locus in patients with multiple primary melanomas
    Puig, S
    Malvehy, J
    Badenas, C
    Ruiz, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P146 - P146
  • [23] Germline splicing mutations of CDKN2A predispose to melanoma
    Loo, JCY
    Liu, L
    Hao, AH
    Gao, LZ
    Agatep, R
    Shennan, M
    Summers, A
    Goldstein, AM
    Tucker, MA
    Deters, C
    Fusaro, R
    Blazer, K
    Weitzel, J
    Lassam, N
    Lynch, H
    Hogg, D
    ONCOGENE, 2003, 22 (41) : 6387 - 6394
  • [24] Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations
    Eskandarpour, M
    Hashemi, J
    Kanter, L
    Ringborg, U
    Platz, A
    Hansson, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (11) : 790 - 798
  • [25] High frequencies of primary multiple melanomas in families with CDKN2A mutations.
    Majore, S
    Catricalà, C
    Binni, F
    De Simone, P
    De Bernardo, C
    Eibenschutz, L
    Grammatico, P
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 109 - 109
  • [26] Familial melanoma: Clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family
    Maubec, Eve
    Chaudru, Valerie
    Mohamdi, Hamida
    Blondel, Christophe
    Margaritte-Jeannin, Patricia
    Forget, Sebastien
    Corda, Eve
    Boitier, Francoise
    Dalle, Stephane
    Vabres, Pierre
    Perrot, Jean-Luc
    Lyonnet, Dominique Stoppa
    Zattara, Helene
    Mansard, Sandrine
    Grange, Florent
    Leccia, Marie-Therese
    Vincent-Fetita, Lynda
    Martin, Ludovic
    Crickx, Beatrice
    Joly, Pascal
    Thomas, Luc
    Bressac-de Paillerets, Brigitte
    Avril, Marie-Francoise
    Demenais, Florence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) : 1257 - U252
  • [27] CDKN2A germline mutations in Swedish kindreds with hereditary cutaneous melanomas
    Hansson, J
    Platz, A
    Hashemi, J
    Stierner, U
    Ringborg, U
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S369 - S369
  • [28] Efficacy of novel melanoma treatments in metastatic melanoma patients with germline CDKN2A mutations
    Helgadottir, Hildur
    Ghiorzo, Paola
    van Doorn, Remco
    Puig, Susana
    Levin, Max
    Kefford, Richard
    Queirolo, Paola
    Pastorino, Lorenza
    Lauss, Martin
    Olsson, Hakan
    Hoiom, Veronica
    Jonsson, Goran
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [29] Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study
    Zebary, Abdlsattar
    Omholt, Katarina
    van Doorn, Remco
    Ghiorzo, Paola
    Harbst, Katja
    Johansson, Carolina Hertzman
    Hoiom, Veronica
    Jonsson, Goran
    Pjanova, Dace
    Puig, Susana
    Scarra, Giovanna B.
    Harland, Mark
    Olsson, Hakan
    Brage, Suzanne Egyhazi
    Palmer, Jane
    Kanter-Lewensohn, Lena
    Vassilaki, Ismini
    Hayward, Nicholas K.
    Newton-Bishop, Julia
    Gruis, Nelleke A.
    Hansson, Johan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (01) : 287 - 290
  • [30] Absence of Germline Epimutation of the CDKN2A Gene in Familial Melanoma
    van Doorn, Remco
    Zoutman, Willem H.
    Gruis, Nelleke A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (03) : 781 - 784